Search For

PSMD14 as a translational target in cancer and beyond: from deubiquitination mechanisms to drug resistance and precision therapy

Resistance to third-generation EGFR TKIs - what can be expected from the fourth-generation?

Bracing for the storm: emerging resistance mechanisms to KRAS inhibitors in pancreatic cancer and strategies to overcome them

TROP2-targeting antibody–drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms

Unraveling resistance to immune checkpoint inhibitors in HNSCC: from mechanisms to combination therapies

Osimertinib acquired resistance among patients with EGFR-mutated NSCLC: from molecular mechanisms to clinical therapeutic strategies

Mechanisms of resistance to antibody-drug conjugates in cancer therapy: molecular basis and therapeutic strategies

Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies

New advances in understanding the mechanisms and treatment challenges of ALK-targeted therapy resistance in lung cancer

Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectives

Antibody-drug conjugates in breast cancer: current resistance mechanisms and future combination strategies

Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumors